Coya Therapeutics licenses Dr. Reddy's Abatacept for COYA 30

Coya will pay a one-time non-refundable upfront fee to Dr Reddy's, and will also owe tiered milestone payments to the company

Related Keywords

Japan , United States , United Kingdom , America , Howardh Berman , Adrian Hepner , Jayanth Sridhar , , South America , Global Head , Dr Reddy S , Coya Therapeutics , Abatacept , Coya 302 ,